STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
61 hedge funds and large institutions have $137M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
Holders
61
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$17.7M | |
| 2 | +$14.4M | |
| 3 | +$7.28M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$7.28M |
| 5 |
SC
Samlyn Capital
New York
|
+$7.28M |
Top Sellers
| 1 | -$2.46M | |
| 2 | -$583K | |
| 3 | -$137K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$126K |
| 5 |
Goldman Sachs
New York
|
-$84.3K |